Hypogonadism
Hypogonadism is a condition characterized by diminished functional activity of the gonads, leading to reduced production of sex hormones such as testosterone in men and estrogen in women, and can cause symptoms like low libido, muscle loss, and depressed mood. It is primarily treated with hormone replacement therapy.
Health Outcomes
- Changed Anti-Müllerian Hormone Level
- Changed Estrogen Level
- Changed Gonadal Hormone Level
- Changed Testosterone Level
- Enhanced Growth Rate
- Enhanced Hormone Normalization
- Gained or Maintained Lean Mass
- Impaired Spermatogenesis
- Improved Assisted Reproductive Outcome
- Improved Average Power
- Improved Bone Density Marker
- Improved Bone Metabolism
- Improved Bone Preservation
- Improved Bone Turnover Marker
- Improved Clinical Pregnancy
- Improved Erectile Function
- Improved Fertility
- Improved Fertility Rate
- Improved Fertilization Rate
- Improved Hormonal Balance
- Improved Hormonal Profile
- Improved Hormonal Response
- Improved Hormonal Status
- Improved Hormone Secretion
- Improved LH/FSHormonal Balance
- Improved Lean Body Mass
- Improved Lean Mass Retention
- Improved Libido
- Improved Male Sexual Function Score
- Improved Maturation Index
- Improved Oocyte Maturity Rate
- Improved Oocyte Recovery
- Improved Ovulation
- Improved Pregnancy Rate
- Improved Quality of Sexual Life
- Improved Reproductive Health
- Improved Reproductive Health Parameters
- Improved Sarcopenia
- Improved Semen Quality
- Improved Sex Hormone Balance
- Improved Sexual Arousal
- Improved Sexual Desire
- Improved Sexual Satisfaction
- Improved Sperm Concentration
- Improved Sperm Count
- Improved Sperm Quality
- Improved Sperm Volume
- Improved Spermatogenesis
- Improved Steroidogenesis
- Improved Testosterone Level
- Improved Total Volumetric Bone Mineral Density
- Increased Appendicular Lean Mass
- Increased Appendicular Muscle Mass
- Increased Blood Protein Levels
- Increased Body Muscle Percentage
- Increased Ejaculation Volume
- Increased Follicle-Stimulating Hormone Level
- Increased Height
- Increased LH Level
- Increased Luteinizing Hormone Level
- Increased Motile Sperm Count
- Increased Sex Hormone-Binding Globulin Level
- Increased Testosterone Production
- Increased Weight Gain Rate
- Inhibited Decline in Bone Mineral Density
- Managed Vasomotor Symptoms
- No Significant Change in Androgen Levels
- Osteoporosis Treatment Strategy
- Preserved Lumbar Bone Mineral Density
- Reduced Androstenedione Level
- Reduced Anti-Müllerian Hormone Level
- Reduced Biochemical Parameter Level
- Reduced Body Temperature
- Reduced Bone Mass
- Reduced Bone Mineral Density
- Reduced Bone Turnover
- Reduced Breast Fullness
- Reduced Estradiol Level
- Reduced Estrogen Rise Rate
- Reduced Follicle Stimulating Hormone
- Reduced Free Androgen Index
- Reduced Free Testosterone Level
- Reduced Gonadal Development Defects
- Reduced Hormone Level
- Reduced Hot Flush Frequency
- Reduced Luteinizing Hormone
- Reduced Luteinizing Hormone Level
- Reduced Ovarian Volume
- Reduced P1NP Level
- Reduced Prostate Size
- Reduced Prostate Specific Antigen Level
- Reduced Recombinant Human Follicle-Stimulating Hormone Dosage
- Reduced Reproductive Function
- Reduced Risk of Primary Breast Cancer
- Reduced SHBG
- Reduced Sexual Dysfunction
- Reduced Testosterone Level
- Reduced Total Prostate-Specific Antigen Level
- Reduced Total Testosterone Level
- Reduced Vasomotor Symptom
- Regulated Hormone Level
- Regulated Ovulation
- Stable Androgen Levels
- Unchanged Offspring Number